This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Suresh's Most Recent Article

Why Spectrum Fell on Beleodaq Approval but Will Rocket on Melphalan Approval

08/18/14 - 07:47 AM EDT

Spectrum's Beleodaq for Non-Hodgkin's lymphoma received FDA approval on July 3, but the stock then fell 26%. The same thing won't happen with Melphalan because sales numbers are already established.

read more >

Other Articles by Suresh

Free Reports

Why Toyota's Move to Fuel Cells Won't Affect Electric Vehicle Sales

07/31/14 - 02:48 PM EDT

Toyota is scrapping its electric vehicle line to go into fuel cells. Is this a step backwards? Not really.

read more >
Why Vertex Pharmaceuticals Will Likely Climb to New High

06/02/14 - 01:26 PM EDT

Vertex Pharmaceuticals is now within weeks, or even days, of announcing top-line results on its two phase 3 cystic fibrosis studies. The science, phase 2 data, and FDA approval history for cystic fibrosis all suggest that Vertex is about to explode higher.

read more >
Page 1 of 1
< Previous
Next >
Top Rated Stocks Top Rated Funds Top Rated ETFs